260 related articles for article (PubMed ID: 21767935)
21. Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma.
Scala S; Ottaiano A; Ascierto PA; Cavalli M; Simeone E; Giuliano P; Napolitano M; Franco R; Botti G; Castello G
Clin Cancer Res; 2005 Mar; 11(5):1835-41. PubMed ID: 15756007
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of a positive nonsentinel lymph node in cutaneous melanoma.
Ghaferi AA; Wong SL; Johnson TM; Lowe L; Chang AE; Cimmino VM; Bradford CR; Rees RS; Sabel MS
Ann Surg Oncol; 2009 Nov; 16(11):2978-84. PubMed ID: 19711133
[TBL] [Abstract][Full Text] [Related]
23. Expression of milk fat globule epidermal growth factor-VIII may be an indicator of poor prognosis in malignant melanoma.
Oba J; Moroi Y; Nakahara T; Abe T; Hagihara A; Furue M
Br J Dermatol; 2011 Sep; 165(3):506-12. PubMed ID: 21574974
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of special AT-rich sequence-binding protein 1 in endometrial cancer: a clinicopathologic study.
Zhang Y; Wang L; Liu Y; Meng F; Wang S; Shang P; Gao Y; Chen X
Int J Gynecol Cancer; 2015 Jan; 25(1):4-11. PubMed ID: 25347096
[TBL] [Abstract][Full Text] [Related]
25. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study.
Crocetti E; Mangone L; Lo Scocco G; Carli P
Melanoma Res; 2006 Oct; 16(5):429-33. PubMed ID: 17013092
[TBL] [Abstract][Full Text] [Related]
26. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.
Statius Muller MG; van Leeuwen PA; de Lange-De Klerk ES; van Diest PJ; Pijpers R; Ferwerda CC; Vuylsteke RJ; Meijer S
Cancer; 2001 Jun; 91(12):2401-8. PubMed ID: 11413531
[TBL] [Abstract][Full Text] [Related]
27. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
[TBL] [Abstract][Full Text] [Related]
28. Lymphovascular invasion as a prognostic factor in melanoma.
Egger ME; Gilbert JE; Burton AL; McMasters KM; Callender GG; Quillo AR; Brown RE; St Hill CR; Hagendoorn L; Martin RC; Stromberg AJ; Scoggins CR
Am Surg; 2011 Aug; 77(8):992-7. PubMed ID: 21944512
[TBL] [Abstract][Full Text] [Related]
29. [Expression of special AT-rich sequence-binding protein in bladder urothelial carcinoma and its clinical significance].
Liu CX; Wen Y; Xu K; Zheng SB; Xu YW; Chen BS
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1389-91, 1394. PubMed ID: 20584685
[TBL] [Abstract][Full Text] [Related]
30. HSP-70, C-myc and HLA-DR expression in patients with cutaneous malignant melanoma metastatic in lymph nodes.
Kalogeraki A; Garbagnati F; Darivianaki K; Delides GS; Santinami M; Stathopoulos EN; Zoras O
Anticancer Res; 2006; 26(5A):3551-4. PubMed ID: 17094481
[TBL] [Abstract][Full Text] [Related]
31. Cytokeratin expression in malignant melanoma: potential application of in-situ hybridization analysis of mRNA.
Chen N; Gong J; Chen X; Xu M; Huang Y; Wang L; Geng N; Zhou Q
Melanoma Res; 2009 Apr; 19(2):87-93. PubMed ID: 19190520
[TBL] [Abstract][Full Text] [Related]
32. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
Debarbieux S; Duru G; Dalle S; BĂ©atrix O; Balme B; Thomas L
Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
[TBL] [Abstract][Full Text] [Related]
33. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis.
Han HJ; Russo J; Kohwi Y; Kohwi-Shigematsu T
Nature; 2008 Mar; 452(7184):187-93. PubMed ID: 18337816
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of SATB1 in laryngeal squamous cell carcinoma.
Zhao XD; Ji WY; Zhang W; He LX; Yang J; Liang HJ; Wang LL
ORL J Otorhinolaryngol Relat Spec; 2010; 72(1):1-5. PubMed ID: 20110741
[TBL] [Abstract][Full Text] [Related]
35. Survival analysis of malignant melanoma in Japan--multivariate analysis of prognostic factors.
Uehara S; Kamo R; Harada T; Ishii M
Osaka City Med J; 2009 Jun; 55(1):35-52. PubMed ID: 19725433
[TBL] [Abstract][Full Text] [Related]
36. Is incisional biopsy of melanoma harmful?
Martin RC; Scoggins CR; Ross MI; Reintgen DS; Noyes RD; Edwards MJ; McMasters KM
Am J Surg; 2005 Dec; 190(6):913-7. PubMed ID: 16307945
[TBL] [Abstract][Full Text] [Related]
37. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.
Roka F; Mastan P; Binder M; Okamoto I; Mittlboeck M; Horvat R; Pehamberger H; Diem E
Eur J Surg Oncol; 2008 Jan; 34(1):82-8. PubMed ID: 17360144
[TBL] [Abstract][Full Text] [Related]
38. Prognostic information from sentinel lymph node biopsy in patients with thick melanoma.
Scoggins CR; Bowen AL; Martin RC; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; Hagendoorn L; McMasters KM
Arch Surg; 2010 Jul; 145(7):622-7. PubMed ID: 20644123
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the proliferation marker MIB-1 in the prognosis of cutaneous malignant melanoma.
Hazan C; Melzer K; Panageas KS; Li E; Kamino H; Kopf A; Cordon-Cardo C; Osman I; Polsky D
Cancer; 2002 Aug; 95(3):634-40. PubMed ID: 12209757
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas.
Dong Y; Sui L; Watanabe Y; Yamaguchi F; Hatano N; Tokuda M
Clin Cancer Res; 2005 Jan; 11(1):259-66. PubMed ID: 15671554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]